首页 | 本学科首页   官方微博 | 高级检索  
检索        

小鼠纤维介素基因shRNA表达质粒的构建及体外RNA干扰
引用本文:汪之沫,严伟明,习东,朱传龙,罗小平,宁琴.小鼠纤维介素基因shRNA表达质粒的构建及体外RNA干扰[J].中华肝脏病杂志,2006,14(5):358-363.
作者姓名:汪之沫  严伟明  习东  朱传龙  罗小平  宁琴
作者单位:1. 湖北十堰郧阳医学院附属东风医院消化内科
2. 430030,武汉,华中科技大学同济医学院附属同济医院感染科、感染免疫研究室
基金项目:国家杰出青年科学基金(30225040),武汉市科技攻关项目(20027006144)
摘    要:目的探讨纤维介素蛋白(fg12)的双链RNA(dsRNA)在体外对fg12凝血酶原酶基因表达的干扰作用及其规律。方法构建能产生鼠fg12(mfg12)的发夹状双链RNA(shRNA)的载体p-mfg12shRNA。将其与mfg12-EGFP融合基因表达质粒pEGFP—mfg12共转染(用量比为1:5)到中国仓鼠卵巢细胞(CHO细胞)作为实验组。另仅转染pEGFP—mfg12或共转染无关序列shRNA表达质粒和pEGFP—mfg12(用量比为1:5)作为对照组。转染24,48、72h后。观察mfg12-EGFP融合蛋白在CHO细胞中的表达情况,并通过流式细胞仪检测荧光细胞阳性率。分别将p—mfg12shRNA和mfg12cDNA表达质粒pcDNA3.1-mfg12共转染(用量比为1:5)到CHO细胞和人宫颈癌细胞(Hela细胞),作为试验组,另转染pcDNA3.1-mfg12或共转染无关序列shRNA表达质粒和pcDNA3.1-mfg12(用量比为1:5)或不转染任何质粒作为对照组。通过逆转录聚合酶链反应和免疫组织化学检测mfg12在CHO和Hela这两种细胞株中表达的情况。结果实验组较对照组的绿色荧光强度明显减弱。荧光细胞数明显减少。在CHO和Hela两种细胞株。均显示mfg12shRNA显著抑制mfg12mRNA和蛋白质的表达。结论本研究所构建的mfg12shRNA表达质粒p-mfg12shRNA可在体外高效特异地抑制mfg12的表达,为进一步的体内实验奠定了基础。

关 键 词:纤维介素蛋白  小鼠  凝血酶原酶  RNA干扰
收稿时间:2005-10-13
修稿时间:2005年10月13

Construction of the p-mfgl2shRNA and its effect on mfg12 expression in vitro
WANG Zhi-mo,YAN Wei-ming,XI Dong,ZHU Chuan-long,LUO Xiao-ping,NING Qin.Construction of the p-mfgl2shRNA and its effect on mfg12 expression in vitro[J].Chinese Journal of Hepatology,2006,14(5):358-363.
Authors:WANG Zhi-mo  YAN Wei-ming  XI Dong  ZHU Chuan-long  LUO Xiao-ping  NING Qin
Institution:Laboratory of Infectious Immunology and Department of Infectious Diseases, Tongji Hospital of Tongji Medical College, Hua Zhong University of Science and Technology, Wuhan 430030, China
Abstract:Objective To construct the siRNA plasmid for mfgl2 gene, which has been reported to be involved in a variety of disease developments including fulminant viral hepatitis, acute rejection of allo/zero transplantation and fetal loss syndrome, and to investigate its inhibitory effects on mfgl2 expression in vitro. Methods A plasmid p-mfgl2shRNA complimentary to the sequerence responsible for the functional domain of mouse fgl2 (mfgl2) was constructed. The pcDNA3.1 mfgl2 expression construct was able to show a satisfactory fgl2 protein expression. The plasmid expression pEGFP and a construct expressing irrelevant shRNA with a random combination of the p-mfgl2shRNA sequence were used as controls. A pEGFP-mfgl2 expressing mfgl2-EGFP fusion protein was also constructed for screening of the effect of p-mfgl2shRNA on the mfgl2 expression. Results Cotransfection of p-mfgl2shRNA with pEGFP-mfgl2 decreased green fluorescent cells and the lightness of fluorescence within the cells at the 24 h, 48 h and 72 h post-transfection when compared with that in the control groups which were solely transfected with pEGFP-mfgl2. Furthermore the mfgl2 expression was significantly reduced when the pcDNA3.1 mfgl2 expression construct was cotransfected with p-mfgl2shRNA both at mRNA level by RT-PCR and protein level by RT-PCR, immunohis-tochemistry staining and FACS in both CHO cell and Hela cell lines. Conclusion The study demonstrated that the construct of p-mfgl2shRNA successfully interfered in the mfgl2 expression in vitro. It provides a basis for a further investigation of effect in
Keywords:fg12/fibroleuki  mouse  Prothrombinase  RNA interference
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号